The application belongs to the field of biological
medicine, and particularly relates to a bivalent
nanoparticle antigen for preventing respiratory syncytial
virus infection and application thereof. The
F protein sequences of two subtypes of RSVA and B and the human
Ferritin protein sequence are connected in series, the post-F specific I and IV
epitope sequences and the pre-F and post-F shared III
epitope partial sequences are removed, and the bivalent
antigen nanoparticle containing the new
F protein of the two subtypes A and B is obtained through the self-
assembly of the
Ferritin protein. The bivalent
nanoparticle antigen has a larger molecular weight, can effectively improve the
immunogenicity of the antigen, stimulate the body to produce more neutralizing antibodies, and produce neutralizing antibodies against the two subtypes A and B of viruses, and is more broad-spectrum.